Invesco
FOLD

Invesco’s Amicus Therapeutics FOLD Stock Holding History

Invesco’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.41M Sell
512,740
-746,485
-59% -$10.7M ﹤0.01% 1998
2025
Q4 		$17.9M Buy
1,259,225
+797,255
+173% +$7.83M ﹤0.01% 1523
2025
Q3 		$3.64M Sell
461,970
-841,994
-65% -$5.99M ﹤0.01% 2371
2025
Q2 		$7.47M Sell
1,303,964
-1,357,430
-51% -$8.76M ﹤0.01% 1961
2025
Q1 		$21.7M Buy
2,661,394
+105,856
+4% +$980K ﹤0.01% 1396
2024
Q4 		$24.1M Buy
2,555,538
+5,480
+0.2% +$57K ﹤0.01% 1395
2024
Q3 		$27.2M Sell
2,550,058
-2,955
-0.1% -$32.2K 0.01% 1319
2024
Q2 		$25.3M Buy
2,553,013
+1,787,125
+233% +$18.3M 0.01% 1321
2024
Q1 		$9.02M Buy
765,888
+600,212
+362% +$7.68M ﹤0.01% 1876
2023
Q4 		$2.35M Sell
165,676
-752,043
-82% -$8.54M ﹤0.01% 2552
2023
Q3 		$11.2M Buy
917,719
+150,641
+20% +$1.94M ﹤0.01% 1683
2023
Q2 		$9.63M Sell
767,078
-165,651
-18% -$1.97M ﹤0.01% 1837
2023
Q1 		$10.3M Buy
932,729
+111,630
+14% +$1.38M ﹤0.01% 1763
2022
Q4 		$10M Buy
821,099
+95,155
+13% +$1.07M ﹤0.01% 1842
2022
Q3 		$7.58M Buy
725,944
+566,417
+355% +$6.31M ﹤0.01% 1970
2022
Q2 		$1.71M Buy
159,527
+7,395
+5% +$60.9K ﹤0.01% 2770
2022
Q1 		$1.44M Sell
152,132
-6,587
-4% -$61.8K ﹤0.01% 2912
2021
Q4 		$1.83M Sell
158,719
-10,814
-6% -$121K ﹤0.01% 2826
2021
Q3 		$1.62M Buy
169,533
+20,439
+14% +$209K ﹤0.01% 2911
2021
Q2 		$1.44M Buy
149,094
+34,432
+30% +$336K ﹤0.01% 2979
2021
Q1 		$1.13M Sell
114,662
-1,701,167
-94% -$26.3M ﹤0.01% 3005
2020
Q4 		$41.9M Sell
1,815,829
-24,259
-1% -$496K 0.01% 1092
2020
Q3 		$26M Buy
1,840,088
+495,707
+37% +$7.22M 0.01% 1178
2020
Q2 		$20.3M Buy
1,344,381
+94,288
+8% +$1.15M 0.01% 1266
2020
Q1 		$11.6M Sell
1,250,093
-5,228,451
-81% -$49.7M ﹤0.01% 1469
2019
Q4 		$63.1M Buy
6,478,544
+521,167
+9% +$4.77M 0.02% 897
2019
Q3 		$47.8M Sell
5,957,377
-40,466
-0.7% -$439K 0.01% 1014
2019
Q2 		$74.9M Buy
5,997,843
+1,111,022
+23% +$14.1M 0.02% 820
2019
Q1 		$66.5M Sell
4,886,821
-447,210
-8% -$5.46M 0.02% 707
2018
Q4 		$51.1M Sell
5,334,031
-283,991
-5% -$3.12M 0.02% 761
2018
Q3 		$67.9M Buy
5,618,022
+1,254,377
+29% +$17.5M 0.02% 723
2018
Q2 		$68.2M Buy
4,363,645
+1,201,458
+38% +$18.2M 0.02% 705
2018
Q1 		$47.6M Buy
3,162,187
+2,754,068
+675% +$41.9M 0.02% 770
2017
Q4 		$5.87M Buy
408,119
+348,977
+590% +$4.79M ﹤0.01% 1880
2017
Q3 		$892K Buy
59,142
+1,449
+3% +$19.2K ﹤0.01% 3064
2017
Q2 		$581K Buy
57,693
+1,046
+2% +$8.42K ﹤0.01% 3273
2017
Q1 		$404K Buy
+56,647
New +$358K ﹤0.01% 3414
2016
Q4 		– Sell
-982,382
Closed -$7.27M – 3689
2016
Q3 		$7.27M Buy
+982,382
New +$6.64M ﹤0.01% 1711
2016
Q2 		– Sell
-1,099,329
Closed -$9.29M – 3694
2016
Q1 		$9.29M Buy
1,099,329
+326,668
+42% +$2.31M ﹤0.01% 1469
2015
Q4 		$7.5M Buy
772,661
+38,725
+5% +$349K ﹤0.01% 1621
2015
Q3 		$10.3M Buy
733,936
+733,545
+187,607% +$11.5M ﹤0.01% 1452
2015
Q2 		$6K Buy
+391
New +$4.7K ﹤0.01% 4117

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Invesco's FOLD Position: Q1 2026 in Review

Invesco reduced its Amicus Therapeutics (FOLD) stake by 59% in Q1 2026, selling an estimated $10.7M and leaving 512,740 shares worth $7.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1998.

Invesco first reported a position in FOLD in Q2 2015 and has held it in 42 quarters since. The position peaked at $74.9M in Q2 2019. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Invesco held 512,740 shares of Amicus Therapeutics worth $7.41M as of Q1 2026.
  • Invesco sold 746,485 Amicus Therapeutics shares in Q1 2026, an estimated $10.7M.
  • Amicus Therapeutics made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #1998 holding.
  • Invesco first reported a position in Amicus Therapeutics in Q2 2015 and has held it in 42 quarters since.
  • Invesco's Amicus Therapeutics position peaked at $74.9M in Q2 2019.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.